InsidersTradesSigma
Track the 上海谊众 share price and the full management transaction log of the company, a publicly traded company based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 上海谊众 has logged 11 insider filings. Market capitalisation: €8.4bn. The latest transaction was disclosed on 30 July 2026 (Purchase). Among the most active insiders: 刘刚. The full history is accessible without an account.
11
Insider Decl.
n/a
Thresholds
€14,230
1 ops.
Buy Volume
€17m
10 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,809 of 29,053 companies
55.1
score / 100
Value34
Quality76
FCF yld-1.8%
Earn yld0.8%
EV/EBITDA·
ROE4.8%
Gross mgn83%
Net mgn20%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 July 2026
Declarations11 total
11 of 11 declarations
About 上海谊众
Shanghai Yizhong is a company operating in the healthcare and pharmaceutical sector, specializing in the research and development of pharmaceutical products. It is listed on the XSHG market.